How long do GLP-1 injections take to work?

Appetite suppression can begin within weeks, with meaningful weight loss often seen within 3 to 6 months. Results depend on dose, lifestyle, and individual response.

Do you regain weight after stopping GLP-1 therapy?

Weight regain can occur unless lifestyle habits — nutrition, movement, and behavioural support — are maintained after stopping. This is why building sustainable habits during treatment matters so much.

Can GLP-1 injections change metabolism?

They don't speed up metabolism directly, but they reduce hunger hormones and improve insulin signalling — reducing the metabolic compensation that makes dieting so difficult to sustain.

Who is eligible for GLP-1 weight loss therapy?

Typically adults with a BMI of 30 or above, or 27 or above with at least one weight-related health condition. Eligibility also depends on medical history and is assessed during a clinical consultation.

Is set point science proven?

Yes. Decades of research support the concept of biological weight regulation, including leptin signalling and hypothalamic control of appetite. GLP-1 medications interact directly with these pathways, which is why their effects go beyond simple calorie restriction.

TribElle blog header for GLP-1 Injections and Weight Set Point: Mounjaro and Wegovy Guide, featuring bold white text on a teal gradient background with scattered teal and grey circles

GLP1s Women's weight loss UK Tirzepatide UK

GLP-1 Injections & Weight Set Point: Mounjaro & Wegovy Guide

J Boora

March 28, 2026

If you've been researching GLP-1 weight-loss injections — such as Mounjaro and Wegovy — you may have also heard talk of the body's "set point." But what is a set point? How does it influence long-term weight loss? And why do GLP-1 medications seem to work when traditional dieting often fails?

This evidence-based guide explains:

→	How GLP-1 injections work

→	What the set point theory is

→	How GLP-1 medications affect set point mechanisms

→	Real clinical trial findings

→	What it means for sustainable weight loss

Reviewed by Julie Boora, Superintendent Pharmacist, TribElle Health Ltd (GPhC Reg. 9012688)

What are GLP-1 weight loss injections?

GLP-1 (glucagon-like peptide-1) receptor agonists are medications that mimic the natural hormone GLP-1, which is released after eating. They help regulate appetite, control hunger signals in the brain, and improve metabolic functions.

Two widely prescribed options include:

Wegovy

Contains semaglutide — a GLP-1 receptor agonist. Learn more in our GLP-1 guide →

Mounjaro

Contains tirzepatide — a dual GLP-1/GIP agonist. Compare both medications →

Both are administered as once-weekly injections and have strong clinical evidence supporting their effectiveness for weight loss and metabolic health.

What set point means in real life for women

The weight set point refers to the idea that each person's body has a preferred or biologically regulated weight range. When you lose weight rapidly through dieting, your body often activates compensatory mechanisms such as:

→	Increased hunger hormones (e.g. ghrelin)

→	Decreased metabolic rate

→	Greater energy efficiency (the body adapts to do more with less)

→	Stronger appetite and food cravings

For women — particularly those in perimenopause, where hormonal shifts amplify these responses — this makes keeping weight off especially challenging. Read our perimenopause and GLP-1 guide →

Why it matters

Traditional dieting often fails because it does not alter the physiological drivers of weight regulation — like appetite and metabolic compensation. It fights the biology. GLP-1 medications work with it.

How GLP-1 injections influence set point mechanisms

Unlike calorie-focused diets alone, GLP-1 receptor agonists work on pathways that directly influence the neurological and metabolic drivers of appetite — effectively shifting the set point over time.

1	Appetite regulation GLP-1 injections act directly in the brain's hunger and reward centres to reduce appetite and food reward drive — quieting the "food noise" that makes dieting so exhausting.

2	Slower gastric emptying Food stays in the stomach longer, enhancing fullness and reducing the urge to eat again soon after a meal.

3	Hormonal balance They may reduce hunger signalling hormones and improve insulin sensitivity, making your body more receptive to sustained weight changes rather than fighting to restore the old set point.

This combination helps reset many of the biological drivers that worked against you during dieting.

What clinical trials tell us

Wegovy (semaglutide) — STEP programme

→	Average weight loss of ~15% over 68 weeks

→	Significant improvements in cardiometabolic risk

→	Greater weight loss than standard lifestyle intervention alone

Wilding JPH et al. 2021 — NEJM

Mounjaro (tirzepatide) — SURMOUNT-1

→	Average weight loss approaching ~20% at higher doses

→	Superior reductions in hunger scores compared to placebo

→	Strong improvements in metabolic biomarkers

Jastreboff AM et al. 2022 — NEJM

These findings suggest that GLP-1 (and dual-agonist) therapies impact the biological feedback loops that regulate appetite and weight — shifting the body's perceived set point rather than merely suppressing hunger short-term.

GLP-1 vs lifestyle alone: set point comparison

Factor	Traditional dieting	GLP-1 medications
Appetite regulation	Weak	Strong
Hunger hormone response	Increases	Decreases
Metabolic compensation	High	Reduced
Long-term maintenance	Low	Higher with support
Clinical evidence	Limited	Strong (STEP, SURMOUNT)

This does not mean effortless weight loss

These treatments can make weight loss more achievable, but they are not a "switch off" button for your body. GLP-1 medications work on biology — they do not override it entirely, and they do not remove the need for effort, consistency, or support.

What "more achievable" actually means

→	Hunger feels more manageable — not absent

→	Food noise reduces — but food choices still matter

→	The biological headwind eases — but the work continues

→	Results vary significantly by person, dose, and lifestyle

Sustainable results usually come from combining medication with long-term lifestyle support and realistic expectations. The medication opens the door — but you still have to walk through it.

Common myths and misconceptions

Myth	You will regain all the weight once you stop

Reality

Weight regain is possible if lifestyle support is not sustained, but GLP-1 medications can give you a window where appetite signals normalise so that healthier habits take root.

Myth	GLP-1 medications are just "diet pills"

Reality

These are medical therapies targeting the underlying physiological drivers of obesity — not a shortcut or a substitute for lifestyle change.

Practical takeaways for sustainable success

To make the most of GLP-1 therapies and support a healthier set point:

🩺	Clinical oversightWork with a clinician to tailor dosing and monitoring

🌱	Protein and movementPrioritise protein intake and muscle-preserving exercise

😴	Sleep and stressAddress sleep, stress, and micronutrient status

🧠	Behavioural supportCombine medication with community, coaching, or clinical support

Set point shift is strongest when medication and lifestyle changes are aligned.

Frequently asked questions

Bottom line

GLP-1 weight-loss injections like Wegovy and Mounjaro go beyond simple appetite suppression. By targeting the neurological and hormonal mechanisms that govern hunger and weight regulation, they help overcome biological resistance — the "set point" — that makes long-term weight loss so hard.

But they are a tool, not a solution. To use them effectively: